Organization · Venture Capital
Sanderling Ventures
Sanderling Ventures is a venture capital firm based in San Mateo, California, specializing in early-stage biomedical investments. Founded in 1979, it focuses on building new companies through close partnerships with entrepreneurs.
Overview
What Sanderling Ventures does
What Sanderling Ventures is
Sanderling Ventures is a venture capital firm based in San Mateo, California, specializing in early-stage biomedical investments. Founded in 1979, it focuses on building new companies through close partnerships with entrepreneurs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1979
- Approximate age
- About 47 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Sanderling Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Sanderling Ventures as a funder
Investment thesis
Sanderling Ventures focuses on building new biomedical companies through early-stage financing and active management, emphasizing close partnerships with entrepreneurs to foster significant company growth.
Focus narrative
Sanderling Ventures invests in early-stage biomedical companies, focusing on sectors such as small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, and medical devices. The firm emphasizes active management and long-term partnerships with entrepreneurs to drive significant growth.
Value beyond capital
Sanderling Ventures adds value to its portfolio companies through active management, providing operational involvement, technical and regulatory expertise, and cost-control strategies to extend financial runway. The firm also contributes management team members and serves as directors, ensuring a hands-on approach to fostering growth.
Focus and fit
- Stages
- Seed · Pre-seed · Series A
- Sectors
- Biotech · Healthcare · Medical Devices
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 90
- Recorded notable exits
- Actimis, Aderis, Advanced Cardiovascular, Altor BioScience, CalciMedica, and Chimerix, plus 3 more
Portfolio context
Notable portfolio companies include Actimis (acquired by Boehringer Ingelheim), Aderis (acquired by Schwarz Pharma), Advanced Cardiovascular (acquired by Guidant Corp.), Altor BioScience (acquired by ImmunityBio, Inc.), CalciMedica (listed on NASDAQ), Chimerix (listed on NASDAQ), Dendreon (listed on NASDAQ), Dynavax (listed on NASDAQ), Regeneron (listed on NASDAQ), and TheraVida (a private biotechnology company).
Common questions
What to know about Sanderling Ventures
Upseed classifies Sanderling Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.